Periprosthetic joint infections (PJIs) of the trapeziometacarpal joint of the thumb are rare but challenging complications of arthroplasty. Currently, no hand-specific guidelines exist. This study aimed to develop consensus-based recommendations for their diagnosis and management.
Methods:
A three-round Delphi process was conducted with seven European hand surgeons experienced in trapeziometacarpal joint arthroplasty. Consensus was defined as ⩾80% agreement (strong) and 65–79% (moderate). A scoping literature review of hand and large-joint PJIs was performed to support expert statements.
Results:
All suspected infections were recommended to be managed surgically, with strong support for debridement and prosthesis neck exchange in acute infections. Trapeziectomy was endorsed as a salvage strategy in acute and chronic cases. Six weeks of antibiotic therapy, initiated intravenously and followed by oral administration, was strongly recommended. Amoxicillin/clavulanate and clindamycin were preferred empirical agents. The use of rifampicin was conditionally supported in confirmed Staphylococcus aureus infections. A 12-week interval between intraarticular corticosteroid injection and prosthesis implantation was recommended.
Discussion:
This Delphi process, supported by literature review, provides the first structured guidance for the management of PJIs of the trapeziometacarpal joint of the thumb. Recommendations align with principles from large-joint infection management but are tailored to the anatomical and clinical context of the hand. These statements establish a practical framework for clinical decision-making and highlight priorities for future research.
AggarwalVKHigueraCDeirmengianGParviziJAustinMS.Swab cultures are not as effective as tissue cultures for diagnosis of periprosthetic joint infection. Clin Orthop Relat Res. 2013, 471: 3196–203.
2.
BaumsMHAquilinaJPérez-PrietoDSleimanOGeropoulosGTotlisT.Risk analysis of periprosthetic knee joint infection (PJI) in total knee arthroplasty after preoperative corticosteroid injection: a systematic review: a study performed by the early-osteoarthritis group of ESSKA–European Knee Associates Section. Arch Orthop Trauma Surg. 2023, 143: 2683–91.
3.
BeckerAKreitmannLTriffaut-FillitC, et al. Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France. J Bone Jt Infect. 2020, 5: 28–34.
4.
BernardLArvieuxCBrunschweilerB, et al. Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N Engl J Med. 2021, 384: 1991–2001.
5.
BhattacharjeeSWallaceSLuuHHShiLLLeeMJChenAF.Do we need to wait 3 months after corticosteroid injections to reduce the risk of infection after total knee arthroplasty?J Am Acad Orthop Surg. 2021, 29: e714–21.
6.
BlomAWLenguerrandEStrangeS, et al. Clinical and cost effectiveness of single stage compared with two stage revision for hip prosthetic joint infection (INFORM): pragmatic, parallel group, open label, randomised controlled trial. BMJ. 2022, 379: e071281.
7.
BoyerBCazorlaC.Methods and probability of success after early revision of prosthetic joint infections with debridement, antibiotics and implant retention. Orthop Traumatol Surg Res. 2021, 107: 102774.
8.
CalkinsTECulvernCNamD, et al. Dilute betadine lavage reduces the risk of acute postoperative periprosthetic joint infection in aseptic revision total knee and hip arthroplasty: a randomized controlled trial. J Arthroplasty. 2020, 35: 538–43.e1.
9.
CerlierAGuinardDGayAMLegréR. Outcomes of secondary trapeziectomy after revision of trapeziometacarpal implants: a retrospective comparative matched study. J Hand Surg Eur. 2021, 46: 1096–100.
10.
ChaoCAKhilnaniTKJoSShenoyABostromMPGCarliAV.Not all antiseptic solutions are equivalent in removing biofilm: a comparison across different orthopaedic surfaces. J Bone Joint Surg Am. 2025, 107: 127–33.
11.
ChristopherZKTranCPVernonBLSpangehlMJ.What is the duration of irrigation? An in vitro study of the minimum exposure time to eradicate bacteria with irrigation solutions. J Arthroplasty. 2022, 37: 385–9.e2.
12.
EdwardsCSheppardNN.Prevention, diagnosis, and treatment of implant infection in the distal upper extremity. J Hand Surg Am. 2018, 43: 68–74.
13.
El HelouOCBerbariEFLahrBD, et al. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010, 29: 961–7.
14.
GattrellWTLogulloPvan ZuurenEJ, et al. Accord (accurate consensus reporting document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi. PLoS Med. 2024, 21: e1004326.
15.
GonzalezMRAcostaJIDavisJLariosFOlsenASChenAF.What are the research highlights of periprosthetic joint infections from the 100 most cited studies?Arthroplast Today. 2024, 30: 101564.
16.
GrammatopoulosGBolducMEAtkinsBL, et al. Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: a case–control study. Bone Joint J. 2017, 99-B: 614–22.
17.
HamiltonTPalmerAKendrickBAlvandA.Prosthetic joint infection in the hip and knee. Orthop Trauma. 2023, 37: 353–8.
18.
HansenTBHomiliusM.Failed total carpometacarpal joint prosthesis of the thumb: results after resection arthroplasty. Scand J Plast Reconstr Surg Hand Surg. 2010, 44: 171–4.
19.
HaugenIKEnglundMAliabadiP, et al. Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study. Ann Rheum Dis. 2011, 70: 1581–6.
20.
HofmannAAGoldbergTDTannerAMCookTM.Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty. 2005, 20: 874–9.
21.
HøibyNBjarnsholtTMoserC, et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect. 2015, 21 Suppl 1: S1–25.
22.
HolmeTJKarbowiakMClementsJSharmaRCraikJEllaheeN.Thumb CMCJ prosthetic total joint replacement: a systematic review. EFORT Open Rev. 2021, 6: 316–30.
23.
HoushianSSeyedipourSWedderkoppN.Epidemiology of bacterial hand infections. Int J Infect Dis. 2006, 10: 315–9.
JiaYChenJLiangWXiongYPengZWangG.Differences in efficacy between short- and long-course antibiotic agents for joint prosthesis infection: a systematic review and meta-analysis. Surg Infect (Larchmt). 2022, 23: 616–24.
KaszapBDaeckeWJungM.Outcome comparison of primary trapeziectomy versus secondary trapeziectomy following failed total trapeziometacarpal joint replacement. J Hand Surg Am. 2013, 38: 863–71.e3.
28.
KildowBJDella-ValleCJSpringerBD.Single vs 2-stage revision for the treatment of periprosthetic joint infection. J Arthroplasty. 2020, 35: S24–30.
29.
KułakowskiMElsterKSzymczakM, et al. Comparison of the effect of combined usage of povidone–iodine irrigation and topical vancomycin powder to the use of povidone–iodine irrigation alone on the periprosthetic joint infection incidence rate in patients undergoing primary total hip and knee arthroplasty: a protocol for multicenter prospective randomized clinical trial. Trials. 2024, 25: 468.
30.
LiHKRombachIZambellasR, et al. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019, 380: 425–36.
31.
Lora-TamayoJMurilloOIribarrenJA, et al. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis. 2013, 56: 182–94.
32.
Lora-TamayoJMancheño-LosaMMeléndez-CarmonaMHernández-JiménezPBenitoNMurilloO.Appropriate duration of antimicrobial treatment for prosthetic joint infections: a narrative review. Antibiotics (Basel). 2024, 13: 293.
33.
MeierRWirthTHahnFVögelinESendiP.Pyogenic arthritis of the fingers and the wrist: can we shorten antimicrobial treatment duration?Open Forum Infect Dis. 2017, 4: ofx058.
34.
MeierRWirthTVögelinESendiP.Characteristics and outcome of twenty-nine implant-related infections of the hand and fingers: results from a twelve-year observational study. Surg Infect (Larchmt). 2018, 19: 729–34.
35.
MoyadTFThornhillTEstokD.Evaluation and management of the infected total hip and knee. Orthopedics. 2008, 31: 581–8; quiz 9-90.
36.
NdiayeDRaimbeauGJeudyJ, et al. Septic arthritis of the fingers: is short-term oral antibiotic therapy appropriate?Hand Surg Rehabil. 2022, 41: 240–5.
37.
O’DonnellJAWuMCochraneNH, et al. Efficacy of common antiseptic solutions against clinically relevant microorganisms in biofilm. Bone Joint J. 2021, 103-B: 908–15.
38.
OsmonDRBerbariEFBerendtAR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013, 56: e1–e25.
39.
PedeutourBJagerTStrugarekC, et al. Résultats de la prothèse trapézo-métacarpienne maia dans la rhizarthrose à plus de 4 ans. Chir Main. 2014, 33: 435.
40.
RiesgoAMParkBKHerreroCPYuSSchwarzkopfRIorioR.Vancomycin povidone–iodine protocol improves survivorship of periprosthetic joint infection treated with irrigation and debridement. J Arthroplasty. 2018, 33: 847–50.
41.
SalarOPhillipsJPorterR.Diagnosis of knee prosthetic joint infection; aspiration and biopsy. Knee. 2021, 30: 249–53.
42.
ShohatNGohGSHarrerSLBrownS.Dilute povidone-iodine irrigation reduces the rate of periprosthetic joint infection following hip and knee arthroplasty: an analysis of 31,331 cases. J Arthroplasty. 2022, 37: 226–31.e1.
43.
SigmundIKMcNallyMALugerMBöhlerCWindhagerRSulzbacherI.Diagnostic accuracy of neutrophil counts in histopathological tissue analysis in periprosthetic joint infection using the ICM, IDSA, and EBJIS criteria. Bone Joint Res. 2021, 10: 536–47.
44.
SigmundIKYeghiazaryanLLugerMWindhagerRSulzbacherIMcNallyMA. Three to six tissue specimens for histopathological analysis are most accurate for diagnosing periprosthetic joint infection. Bone Joint J. 2023, 105-B: 158–65.
45.
TangJBGiddinsG. Why and how to report surgeons’ levels of expertise. J Hand Surg Eur. 2016, 41: 365–6.
46.
TeissierJAlkarF.La prothèse trapézométacarpienne maia® dans la rhizarthrose. Revue de 100 prothèses à plus de 3 ans. Chir Main. 2011, 30: 77–82.
47.
ToffoliATeissierJ.MAÏA trapeziometacarpal joint arthroplasty: clinical and radiological outcomes of 80 patients with more than 6 years of follow-up. J Hand Surg Am. 2017, 42: 838.e1–.e8.
48.
VeermanKRaessensJTelgtDSmuldersKGoosenJHM. Debridement, antibiotics, and implant retention after revision arthroplasty: antibiotic mismatch, timing, and repeated dair associated with poor outcome. Bone Joint J. 2022, 104-B: 464–71.
49.
WijkUWollmarkMKopylovPTägilM.Outcomes of proximal interphalangeal joint pyrocarbon implants. J Hand Surg Am. 2010, 35: 38–43.
50.
YusufEBramerWAnasAA.Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: a systematic review and meta-analysis. Int J Antimicrob Agents. 2024, 63: 107015.
51.
ZarutaDAQiuBLiuAYRicciardiBF.Indications and guidelines for debridement and implant retention for periprosthetic hip and knee infection. Curr Rev Musculoskelet Med. 2018, 11: 347–56.
52.
ZimmerliW.Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol. 2006, 20: 1045–63.
53.
ZlotnickiJGabrielliAUrishKLBrothersKM.Clinical evidence of current irrigation practices and the use of oral antibiotics to prevent and treat periprosthetic joint infection. Orthop Clin North Am. 2021, 52: 93–101.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
